Darolutamide combo is a sensible option for mHSPC

Nature Reviews Clinical Oncology, Published online: 08 March 2022; doi:10.1038/s41571-022-00616-2Darolutamide combo is a sensible option for mHSPC

Source: Nature Reviews Clinical Oncology - March 8, 2022 Category: Cancer & Oncology Authors: Annette Fenner Source Type: research